Prognostic and predictive role of circulating tumor DNA (ctDNA) in stage III colon cancer treated with celecoxib: Findings from CALGB (Alliance)/SWOG 80702.

MLA

Nowak, Jonathan Andrew, et al. “Prognostic and Predictive Role of Circulating Tumor DNA (CtDNA) in Stage III Colon Cancer Treated with Celecoxib: Findings from CALGB (Alliance)/SWOG 80702.” Journal of Clinical Oncology, vol. 43, Feb. 2025, p. LBA14. EBSCOhost, https://doi.org/10.1200/JCO.2025.43.4_suppl.LBA14.

APA

Nowak, J. A., Shi, Q., Twombly, T., Pederson, L. D., Ma, C., Väyrynen, J. P., Zhao, M. M., Takashima, Y., Shergill, A., Kumar, P., Couture, F., Kuebler, J. P., Krishnamurthi, S. S., Tan, B. R., O’Reilly, E. M., Shields, A. F., Ogino, S., Aleshin, A., & Meyerhardt, J. A. (2025). Prognostic and predictive role of circulating tumor DNA (ctDNA) in stage III colon cancer treated with celecoxib: Findings from CALGB (Alliance)/SWOG 80702. Journal of Clinical Oncology, 43, LBA14. https://doi.org/10.1200/JCO.2025.43.4_suppl.LBA14

Chicago

Nowak, Jonathan Andrew, Qian Shi, Tyler Twombly, Levi D. Pederson, Chao Ma, Juha P. Väyrynen, Melissa M. Zhao, et al. 2025. “Prognostic and Predictive Role of Circulating Tumor DNA (CtDNA) in Stage III Colon Cancer Treated with Celecoxib: Findings from CALGB (Alliance)/SWOG 80702.” Journal of Clinical Oncology 43 (February): LBA14. doi:10.1200/JCO.2025.43.4_suppl.LBA14.